Chandra R. Tate

639 total citations
9 papers, 526 citations indexed

About

Chandra R. Tate is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Chandra R. Tate has authored 9 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Chandra R. Tate's work include Menopause: Health Impacts and Treatments (3 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Estrogen and related hormone effects (2 papers). Chandra R. Tate is often cited by papers focused on Menopause: Health Impacts and Treatments (3 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Estrogen and related hormone effects (2 papers). Chandra R. Tate collaborates with scholars based in United States and France. Chandra R. Tate's co-authors include Matthew E. Burow, Bridgette M. Collins‐Burow, Lyndsay V. Rhodes, H. Chris Segar, F. Nell Pounder, Jennifer Driver, Franck Mauvais‐Jarvis, Steven Elliott, Hope E. Burks and Corinne Leloup and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Experimental Cell Research.

In The Last Decade

Chandra R. Tate

9 papers receiving 520 citations

Peers

Countries citing papers authored by Chandra R. Tate

Since Specialization

Citations

This map shows the geographic impact of Chandra R. Tate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandra R. Tate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandra R. Tate more than expected).

Fields of papers citing papers by Chandra R. Tate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandra R. Tate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandra R. Tate. The network helps show where Chandra R. Tate may publish in the future.

Co-authorship network of co-authors of Chandra R. Tate

This figure shows the co-authorship network connecting the top 25 collaborators of Chandra R. Tate. A scholar is included among the top collaborators of Chandra R. Tate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandra R. Tate. Chandra R. Tate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women 2020 ·European Journal of Endocrinology ·Kara L. Marlatt, Dragana Lovre, Robbie A. Beyl, Chandra R. Tate, (unknown), Charles Burant, Éric Ravussin, Franck Mauvais‐Jarvis	15
2	Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal Women 2019 ·Journal of the Endocrine Society ·Dragana Lovre, Erin Peacock, (unknown), Cynthia Moreau, Beibei Xu, Chandra R. Tate, Kristina M. Utzschneider, Jean–François Gautier, Vivian Fonseca, Franck Mauvais‐Jarvis	9
3	Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1 2015 ·Oncogenesis ·Lyndsay V. Rhodes, Chandra R. Tate, Van T. Hoang, Hope E. Burks, (unknown), Elizabeth C. Martin, S G Elliott, (unknown), Aaron Buechlein, Douglas B. Rusch, Haixu Tang, Kenneth P. Nephew, Matthew E. Burow, Bridgette M. Collins‐Burow	26
4	Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis 2015 ·Scientific Reports ·Joseph P. Tiano, Chandra R. Tate, Bin Yang, Richard D. DiMarchi, Franck Mauvais‐Jarvis	37
5	Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators 2014 ·Breast Cancer Research and Treatment ·Lyndsay V. Rhodes, Chandra R. Tate, H. Chris Segar, Hope E. Burks, Theresa B. Phamduy, Van T. Hoang, Steven Elliott, (unknown), F. Nell Pounder, Muralidharan Anbalagan, Douglas B. Chrisey, Brian G. Rowan, Matthew E. Burow, Bridgette M. Collins‐Burow	81
6	Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice 2014 ·Molecular Metabolism ·Jun‐Ho Kim, (unknown), Saja S. Khuder, (unknown), Harrison T. Muturi, Lucia Russo, Chandra R. Tate, Andrea L. Hevener, Sonia M. Najjar, Corinne Leloup, Franck Mauvais‐Jarvis	93
7	Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat 2012 ·Breast Cancer Research ·Chandra R. Tate, Lyndsay V. Rhodes, H. Chris Segar, Jennifer Driver, F. Nell Pounder, Matthew E. Burow, Bridgette M. Collins‐Burow	219
8	Effects of SDF-1–CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells 2011 ·Experimental Cell Research ·Lyndsay V. Rhodes, Melyssa R. Bratton, Yun Zhu, Syreeta L. Tilghman, Shannon E. Muir, Virgilio A. Salvo, Chandra R. Tate, Steven Elliott, Kenneth P. Nephew, Bridgette M. Collins‐Burow, Matthew E. Burow	30
9	Peripheral synthesis and isoform distribution of dog apoprotein E. An in vivo approach. 1986 ·Journal of Biological Chemistry ·Ladislav Dory, (unknown), Chandra R. Tate, C H Sloop	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact